vTv Therapeutics Inc., a late-stage biopharmaceutical company, focuses on developing oral small molecule drug candidates intended to treat people living with diabetes and other chronic diseases. Its lead drug candidate is cadisegliatin (TTP...
Q1 2026
May 13, 2026
FY 2025
Mar 10, 2026
Q4 2025
Q3 2025
Nov 6, 2025
Q2 2025
Aug 12, 2025